Dr. Hongcang Gu is the co-founder and chief scientist of ShengTing Medical Technology. He currently serves as a Primary Investigator (PI) at the Institute of Health and Medical Technology, Hefei Institutes of Physical Sciences, Chinese Academy of Sciences, and is a doctoral supervisor at the University of Science and Technology of China. He earned his Ph.D. degree from the University of Kentucky in the United States in 2004. From August 2004 to July 2006, Dr. Gu conducted postdoctoral research in the Department of Pathology at Harvard Medical School. In July 2006, he joined the Broad Institute of Harvard and MIT as a Research Scientist I and then was promoted to Research Scientist II in July 2013, a position he held until June 2018. From July 2018 to June 2020, Dr. Gu participated in the Medical Genetics Specialty Qualification Training, a collaboration between the American Board of Medical Genetics and Genomics (ABMGG) and the University of Oklahoma College of Medicine. He currently holds board certification for Laboratory of Genetics and Genomics (LGG). Dr. Gu has published 67 papers in prestigious journals, including Nature, Nature Methods, Nature Communications, and Nature Protocols. His publications have received more than 25,000 citations.